Cannabis Science, Inc., formerly Gulf Onshore Inc., is a development-stage company. The Company is engaged in the pharmaceutical cannabis industry. The Company is focused to develop, produce, commercialize, a variety of whole plant cannabinoid-based pharmaceutical products. The Company is focused to pursue the development of blood pressure and cancer medications. The endocannabinoid system normally regulates blood pressure through its capacity to dilate blood vessels and reduce adrenergic stimuli. On March 30, 2009, the Company entered into an agreement with Cannex Therapeutics, LLC. The asset purchase agreement includes all of Cannex’ intellectual property rights, formulas, patents, trademarks, client base, hardware and software, including the Website www.phytiva.com.